| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9321 |
| Human Intestinal Absorption | HIA- | 0.5000 |
| Caco-2 Permeability | Caco2- | 0.6797 |
| P-glycoprotein Substrate | Non-substrate | 0.8763 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9321 |
| Non-inhibitor | 0.9919 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9528 |
| Distribution |
| Subcellular localization | Mitochondria | 0.5454 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8323 |
| CYP450 2D6 Substrate | Non-substrate | 0.8247 |
| CYP450 3A4 Substrate | Non-substrate | 0.7299 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8642 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8410 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9137 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8559 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9867 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9814 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8806 |
| Non-inhibitor | 0.9240 |
| AMES Toxicity | Non AMES toxic | 0.8908 |
| Carcinogens | Carcinogens | 0.8269 |
| Fish Toxicity | Low FHMT | 0.5560 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.8210 |
| Honey Bee Toxicity | High HBT | 0.7265 |
| Biodegradation | Not ready biodegradable | 0.5830 |
| Acute Oral Toxicity | III | 0.7594 |
| Carcinogenicity (Three-class) | Non-required | 0.7075 |